Rockwell Medical (RMTI) Other Non-Current Liabilities (2010 - 2025)
Rockwell Medical (RMTI) posted Other Non-Current Liabilities of $500000.0 for Q1 2025, down 50.0% on a QoQ basis from $1.0 million in Q4 2024, and up 3471.43% year-over-year from $14000.0 in Q1 2024.
Rockwell Medical (RMTI) Other Non-Current Liabilities (2010 - 2025) Analysis & Trends
Rockwell Medical's Other Non-Current Liabilities history runs 10 years deep, the most recent figure standing at $500000.0 for Q1 2025.
- Quarterly Other Non-Current Liabilities rose 3471.43% year-over-year to $500000.0 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $500000.0 (up 3471.43% YoY) and the FY2024 annual result came in at $1.0 million, up 7042.86% from the prior year.
- Other Non-Current Liabilities was $500000.0 for Q1 2025 at Rockwell Medical, down from $1.0 million in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $2.5 million in Q3 2023 and bottomed at $14000.0 in Q4 2021.
- A 5-year average of $318461.5 and a median of $14000.0 in 2021 frame the typical range for Other Non-Current Liabilities.
- Annual changes were most pronounced in 2023 — Other Non-Current Liabilities jumped 17757.14% — and 2024, when it sank 99.44%.
- Rockwell Medical's Other Non-Current Liabilities stood at $14000.0 in 2021, then changed by 0.0% to $14000.0 in 2022, then changed by 0.0% to $14000.0 in 2023, then soared by 7042.86% to $1.0 million in 2024, then plunged by 50.0% to $500000.0 in 2025.
- Business Quant data shows RMTI's Other Non-Current Liabilities at $500000.0 in Q1 2025, $1.0 million in Q4 2024, and $14000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Rockwell Medical | 25.77 Mn | 1.88 Mn | 2.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 500,000.00 |
| Dec 31, 2024 | 1.00 Mn |
| Sep 30, 2024 | 14,000.00 |
| Jun 30, 2024 | 14,000.00 |
| Mar 31, 2024 | 14,000.00 |
| Dec 31, 2023 | 14,000.00 |
| Sep 30, 2023 | 2.50 Mn |
| Jun 30, 2023 | 14,000.00 |
| Mar 31, 2023 | 14,000.00 |
| Sep 30, 2022 | 14,000.00 |
| Jun 30, 2022 | 14,000.00 |
| Mar 31, 2022 | 14,000.00 |
| Dec 31, 2021 | 14,000.00 |
| Sep 30, 2014 | 4.23 Mn |
| Jun 30, 2014 | 4.23 Mn |
| Mar 31, 2014 | 4.23 Mn |
| Dec 31, 2013 | 4.90 Mn |
| Sep 30, 2013 | 5.16 Mn |
| Jun 30, 2013 | 7.79 Mn |
| Mar 31, 2013 | 8.00 Mn |